Should I buy or sell Outset Medical stock right now?

5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares. View OM analyst ratings or view top-rated stocks .

What is Outset Medical's stock price target for 2024?

5 brokerages have issued 12 month price objectives for Outset Medical's shares. Their OM share price targets range from $3.00 to $17.00. On average, they expect the company's stock price to reach $7.75 in the next twelve months. This suggests a possible upside of 36.2% from the stock's current price. View analysts price targets for OM or view top-rated stocks among Wall Street analysts .

How have OM shares performed in 2023?

Outset Medical's stock was trading at $25.82 at the beginning of 2023. Since then, OM stock has decreased by 78.0% and is now trading at $5.69. View the best growth stocks for 2023 here .

When is Outset Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 12th 2024. View our OM earnings forecast .

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.93) EPS for the quarter, missing the consensus estimate of ($0.79) by $0.14. The firm had revenue of $30.36 million for the quarter, compared to analysts' expectations of $30.38 million. Outset Medical had a negative trailing twelve-month return on equity of 88.10% and a negative net margin of 133.19%.

What ETFs hold Outset Medical's stock?

ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT) , Procure Disaster Recovery Strategy ETF (FEMA) , BNY Mellon Innovators ETF (BKIV) , SPDR S&P Health Care Equipment ETF (XHE) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG) . iShares U.S. Medical Devices ETF (IHI) .

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical updated its third quarter 2023 earnings guidance on Thursday, October, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $30.40 million-$30.40 million, compared to the consensus revenue estimate of $36.03 million.

When did Outset Medical IPO?

(OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Who are Outset Medical's major shareholders?

Outset Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include FMR LLC (14.87%), JPMorgan Chase & Co. (10.17%), Braidwell LP (4.78%), Ameriprise Financial Inc. (3.49%), Morgan Stanley (3.19%) and Eagle Health Investments LP (3.00%). Insiders that own company stock include D Keith Grossman , James F Hinrichs, James F Hinrichs , Jean-Olivier Racine, John L Brottem, John L Brottem , Leslie Trigg , Martin Vazquez , Nabeel Ahmed , Pincus X LP Warburg, Rebecca Chambers , Stacey L Porter, Steven S Williamson and Warburg Pincus Llc. View institutional ownership trends .

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Outset Medical Stock Price, News & Analysis (NASDAQ:OM)

$5.69

+0.45 (+8.59%)

(As of 12/1/2023 ET)

Compare

Today's Range: $5.19
▼
$5.70
50-Day Range: $3.07
▼
$11.01
52-Week Range: $2.90
▼
$30.55

Volume: 807,822 shs
Average Volume: 1.41 million shs
Market Capitalization: $285.69 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $7.75

Outset Medical MarketRank™ Stock Analysis

Analyst Rating: Hold
2.20 Rating Score
Upside/Downside: 36.2% Upside
$7.75 Price Target
Short Interest: Healthy
15.91% of Shares Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.18
Based on 3 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: Growing
From ($3.45) to ($2.25) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.89 out of 5 stars

Medical Sector

707th out of 955 stocks

Electromedical Equipment Industry

17th out of 23 stocks

3.1

Analyst's Opinion

Consensus Rating
Outset Medical has received a consensus rating of Hold. The company's average rating score is 2.20, and is based on 2 buy ratings, 2 hold ratings, and 1 sell rating.
Price Target Upside/Downside
According to analysts' consensus price target of $7.75, Outset Medical has a forecasted upside of 36.2% from its current price of $5.69.
Amount of Analyst Coverage
Outset Medical has only been the subject of 4 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
15.91% of the outstanding shares of Outset Medical have been sold short.
Short Interest Ratio / Days to Cover
Outset Medical has a short interest ratio ("days to cover") of 6.1.
Change versus previous month
Short interest in Outset Medical has recently decreased by 5.11%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
Outset Medical does not currently pay a dividend.
Dividend Growth
Outset Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for OM.

3.4

News and Social Media Coverage

News Sentiment
Outset Medical has a news sentiment score of 1.18. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.76 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 3 news articles for Outset Medical this week, compared to 2 articles on an average week.
Search Interest
Only 5 people have searched for OM on MarketBeat in the last 30 days. This is a decrease of -50% compared to the previous 30 days.
MarketBeat Follows
4 people have added Outset Medical to their MarketBeat watchlist in the last 30 days.

0.0

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Outset Medical insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 3.70% of the stock of Outset Medical is held by insiders.

0.6

Earnings and Valuation

Earnings Growth
Earnings for Outset Medical are expected to grow in the coming year, from ($3.45) to ($2.25) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Outset Medical is -1.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Outset Medical is -1.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Outset Medical has a P/B Ratio of 1.88. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Outset Medical Stock (NASDAQ:OM)

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Stock Price History

30 days | 90 days | 365 days | Advanced Chart

OM Stock News Headlines

December 2, 2023 | americanbankingnews.com

Outset Medical, Inc. (NASDAQ:OM) Given Average Recommendation of "Hold" by Analysts

November 29, 2023 | finance.yahoo.com

Outset Medical to Present at BofA Home Care Conference

December 3, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 14, 2023 | benzinga.com

Outset Medical Stock (NASDAQ:OM), Analyst Ratings, Price Targets, Predictions

November 9, 2023 | benzinga.com

Outset Medical Stock (NASDAQ:OM) Earnings Dates and Earning Calls

November 9, 2023 | markets.businessinsider.com

Analysts Conflicted on These Healthcare Names: Ascend Wellness Holdings LLC (OtherAAWH), Vertex Pharmaceuticals (VRTX) and Outset Medical (OM)

November 7, 2023 | benzinga.com

Recap: Outset Medical Q3 Earnings

November 7, 2023 | finance.yahoo.com

Outset Medical Reports Third Quarter 2023 Financial Results

December 3, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 6, 2023 | markets.businessinsider.com

TD Cowen Reaffirms Their Buy Rating on Outset Medical (OM)

November 6, 2023 | benzinga.com

A Preview Of Outset Medical's Earnings

November 2, 2023 | finance.yahoo.com

After Plunging -62.36% in 4 Weeks, Here's Why the Trend Might Reverse for Outset Medical, Inc. (OM)

November 2, 2023 | finance.yahoo.com

Analysts Estimate Olink Holding AB (publ) Sponsored ADR (OLK) to Report a Decline in Earnings: What to Look Out for

November 1, 2023 | finance.yahoo.com

New Data Insights Unveiled at ASN Kidney Week 2023 Point to the Impact of the Tablo® Hemodialysis System on Equitable Kidney Care

October 30, 2023 | finance.yahoo.com

Outset Medical to Report Third Quarter 2023 Financial Results on Tuesday, November 7, 2023

October 27, 2023 | benzinga.com

Hagens Berman Encourages Outset Medical (OM) Shareholders with Losses to Contact its Attorneys, Firm Investigating Possible Securities Law Violations

October 23, 2023 | barrons.com

Calling All Outset Medical, Inc. (OM) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Claim Your Losses

October 17, 2023 | finance.yahoo.com

Down -68.16% in 4 Weeks, Here's Why You Should You Buy the Dip in Outset Medical, Inc. (OM)

October 16, 2023 | finance.yahoo.com

Outset Medical, Inc. (NASDAQ:OM) Q3 2023 Earnings Call Transcript

October 14, 2023 | nasdaq.com

Stifel Maintains Outset Medical (OM) Buy Recommendation

October 14, 2023 | msn.com

B of A Securities Downgrades Outset Medical (OM)

October 13, 2023 | benzinga.com

Why Outset Medical Shares Are Plummeting Today

October 13, 2023 | msn.com

Outset tumbles ~40% after Bofa downgrades following guidance cut

October 12, 2023 | seekingalpha.com

Outset Medical expects higher 2023 revenue year on year

October 12, 2023 | finance.yahoo.com

Outset Medical Reports Preliminary Third Quarter 2023 Financial Results

October 12, 2023 | msn.com

Dialysis stocks decline again as Novo Nordisk hits 52-week high

October 11, 2023 | msn.com

Baxter, Outset hit new 52-week lows amid dialysis stocks sell-off

See More Headlines

Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/07/2023
Today: 12/02/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 2/12/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Electromedical equipment
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:OM
CUSIP: N/A
CIK: 1484612
Web: outsetmedical.com
Phone: 669-231-8200
Fax: N/A
Employees: 518
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $7.75
High Stock Price Target: $17.00
Low Stock Price Target: $3.00
Potential Upside/Downside: +36.2%
Consensus Rating: Hold
Rating Score (0-4): 2.20
Research Coverage: 5 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($3.59)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-162,960,000.00
Net Margins: -133.19%
Pretax Margin: -132.83%
Return on Equity: -88.10%
Return on Assets: -50.01%

Debt

Debt-to-Equity Ratio: 0.64
Current Ratio: 5.35
Quick Ratio: 4.44

Sales & Book Value

Annual Sales: $115.38 million
Price / Sales: 2.48
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $3.03 per share
Price / Book: 1.88

Miscellaneous

Outstanding Shares: 50,210,000
Free Float: 48,347,000
Market Cap: $285.69 million
Optionable: Not Optionable
Beta: 2.07

10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

Ms. Leslie L. Trigg (Age 52)
President, CEO & Chairman
Comp: $1.22M
Mr. Nabeel Ahmed (Age 47)
CFO, Principal Financial Officer & Principal Accounting Officer
Comp: $654.74k
Mr. John L. Brottem (Age 49)
General Counsel & Secretary
Comp: $594.15k
Mr. Steven S. Williamson (Age 50)
Chief Commercial Officer
Comp: $788.51k
Marc Nash
Senior Vice President of Operations and R&D
Mr. Jean-Olivier Racine (Age 41)
Chief Technology Officer
Comp: $540.93k
Mr. James S. Mazzola
Head of Investor Relations
Nicole Shannon
Director of Marketing Communications
Ms. Stacey L. Porter (Age 47)
Chief People Officer
Dr. Michael Aragon M.D.
Chief Medical Officer

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

OM Stock Analysis - Frequently Asked Questions

Should I buy or sell Outset Medical stock right now?: 5 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last twelve months. There are currently 1 sell rating, 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares.
View OM analyst ratings or view top-rated stocks.
What is Outset Medical's stock price target for 2024?: 5 brokerages have issued 12 month price objectives for Outset Medical's shares. Their OM share price targets range from $3.00 to $17.00. On average, they expect the company's stock price to reach $7.75 in the next twelve months. This suggests a possible upside of 36.2% from the stock's current price.
View analysts price targets for OM or view top-rated stocks among Wall Street analysts.
How have OM shares performed in 2023?: Outset Medical's stock was trading at $25.82 at the beginning of 2023. Since then, OM stock has decreased by 78.0% and is now trading at $5.69.
View the best growth stocks for 2023 here.
When is Outset Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, February 12th 2024.
View our OM earnings forecast.
How were Outset Medical's earnings last quarter?: Outset Medical, Inc. (NASDAQ:OM) posted its quarterly earnings data on Tuesday, November, 7th. The company reported ($0.93) EPS for the quarter, missing the consensus estimate of ($0.79) by $0.14. The firm had revenue of $30.36 million for the quarter, compared to analysts' expectations of $30.38 million. Outset Medical had a negative trailing twelve-month return on equity of 88.10% and a negative net margin of 133.19%.
What ETFs hold Outset Medical's stock?: ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT), Procure Disaster Recovery Strategy ETF (FEMA), BNY Mellon Innovators ETF (BKIV), SPDR S&P Health Care Equipment ETF (XHE) and First Trust Nasdaq Lux Digital Health Solutions ETF (EKG).iShares U.S. Medical Devices ETF (IHI).

What guidance has Outset Medical issued on next quarter's earnings?: Outset Medical updated its third quarter 2023 earnings guidance on Thursday, October, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $30.40 million-$30.40 million, compared to the consensus revenue estimate of $36.03 million.
When did Outset Medical IPO?: (OM) raised $175 million in an IPO on Tuesday, September 15th 2020. The company issued 7,600,000 shares at a price of $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.
Who are Outset Medical's major shareholders?: Outset Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include FMR LLC (14.87%), JPMorgan Chase & Co. (10.17%), Braidwell LP (4.78%), Ameriprise Financial Inc. (3.49%), Morgan Stanley (3.19%) and Eagle Health Investments LP (3.00%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Martin Vazquez, Nabeel Ahmed, Pincus X LP Warburg, Rebecca Chambers, Stacey L Porter, Steven S Williamson and Warburg Pincus Llc.
View institutional ownership trends.
How do I buy shares of Outset Medical?: Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:OM) was last updated on 12/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial